Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell membrane and cell wall structures are essential components that maintain the viability and integrity of fungal cells. The cell wall is a rigid outer layer composed of a complex network of polysaccharides, including chitin, beta-1,3-glucan, and beta-1,6-glucan, along with various mannoproteins (Gow et al., 2017, Nature Reviews Microbiology). This structure provides protection against environmental stress and osmotic pressure, which is absent in human cells, making it an ideal target for selective antifungal therapy (Gow et al., 2017). Beneath the cell wall lies the plasma membrane, which is characterized by the presence of ergosterol, a sterol that fulfills a similar role to cholesterol in animal cells by regulating membrane fluidity and permeability (Odds et al., 2003, Journal of Antimicrobial Chemotherapy). Many antifungal drug classes exploit these unique features: polyenes like amphotericin B bind directly to ergosterol to form lethal pores, while azoles and allylamines inhibit enzymes in the ergosterol biosynthetic pathway (Sant et al., 2016, Journal of Applied Microbiology). Echinocandins specifically target the cell wall by inhibiting the synthesis of beta-1,3-glucan, leading to cell lysis (Denning, 2003, The Lancet). These structures are central to the pathogenesis of various fungal infections, ranging from superficial skin conditions to life-threatening systemic mycoses.
Disruption of membrane integrity via ergosterol binding (polyenes), inhibition of ergosterol biosynthesis via 14-alpha-demethylase or squalene epoxidase inhibition (azoles, allylamines), and inhibition of beta-1,3-glucan synthesis (echinocandins) (StatPearls, Antifungal Agents; Odds et al., 2003, Journal of Antimicrobial Chemotherapy).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell membrane and cell wall structures.